http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e7f13031de25783517d3f9e4c4a5343
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sekido |
| name | Yoshitaka Sekido |
| given-name | Yoshitaka |
| organization-name | Division of Cancer Biology Aichi Cancer Center Research Institute 1-1, Kanokoden Chikusa-Ku Nagoya Aichi 464-8681 Japan Authors' Affiliations: 1Department of Neurosurgery, Nagoya University School of Medicine; Divisions of 2Epigenomics and 3Molecular Oncology, Aichi Cancer Center Research Institute; 4Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences; 5Department of Scientific and Engineering Simulation, Graduate School of Engineering, Nagoya Institute of Technology; 6Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya; 7Institute for Integrated Cell-Material Sciences/Institute for Chemical Research, Kyoto University, Kyoto; 8Department of Physiology, Keio University School of Medicine; 9Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Tokyo, Japan; 10Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada; 11Medical Research Institute, Chungang University College of Medicine, Seoul, Republic of Korea; and 12Fels Institute for Cancer Re; Authors' Affiliations: 1Department of Neurosurgery, Nagoya University School of Medicine; Divisions of 2Epigenomics and 3Molecular Oncology, Aichi Cancer Center Research Institute; 4Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences; 5Department of Scientific and Engineering Simulation, Graduate School of Engineering, Nagoya Institute of Technology; 6Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya; 7Institute for Integrated Cell-Material Sciences/Institute for Chemical Research, Kyoto University, Kyoto; 8Department of Physiology, Keio University School of Medicine; 9Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Tokyo, Japan; 10Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, Canada; 11Medical Research Institute, Chungang University College of Medicine, Seoul, Republic of Korea; and 12Fels Institute for Cancer Re Division of Molecular Oncology; Aichi Cancer Center Research Institute; Nagoya; Japan H. C. Simmons Comprehensive Cancer Center, University of Texas at Dallas, Dallas, Texas 75235 Divisions of 1Molecular Oncology and 2Epidemiology and Prevention, Aichi Cancer Center Research Institute; Departments of 3Cancer Genetics and 4Respiratory Medicine and 5Division of General Thoracic Surgery, Nagoya University Graduate School of Medicine; 6Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; 7Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 8Department of Biochemistry and 9First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; 10Department of General Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 11Department of Biomedical Sciences, Chubu University, Kasugai, Japan; and 12Department of Respiratory Medicine, Okayama Rosai Hospital, Okayama, Japan; Divisions of 1Molecular Oncology and 2Epidemiology and Prevention, Aichi Cancer Center Research Institute; Departments of 3Cancer Genetics and 4Respiratory Medicine and 5Division of General Thoracic Surgery, Nagoya University Graduate School of Medicine; 6Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; 7Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 8Department of Biochemistry and 9First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; 10Department of General Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 11Department of Biomedical Sciences, Chubu University, Kasugai, Japan; and 12Department of Respiratory Medicine, Okayama Rosai Hospital, Okayama, Japan Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan; Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, 464-8681, Japan Division of Molecular Oncology 1 and 2 ; and 3 and 4; Division of Oncological Pathology, Aichi Cancer Center Research Institute 1 and 2 ; and 3 and 4; Department of Pathology and Molecular Diagnostics 1 and 2 ; and 3 and 4; Department of Thoracic Oncology, Aichi Cancer Center Hospital; Aichi Cancer Center, Chikusa-ku, Nagoya 464-8681, Japan 1 and 2 ; and 3 and 4; Department of Cancer Genetics, Program in Function Construction Medicine, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan 7 Authors' Affiliations: Divisions of 1Medical Oncology and 2Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Ishikawa, Japan; 3Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan; and 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan Division of Molecular Oncology Aichi Cancer Center Research Institute Nagoya Japan Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan; Department of Cancer Genetics, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan Aichi Cancer Center Research Institute, Nagoya, Aichi 464-8681, Japan; Authors' Affiliations: 1Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 2Department of Respiratory Medicine, Nagoya University; 3Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi; and 4Tsukuba Research Laboratories, Eisai Co., ltd., Ibaraki, Japan Division of Cancer Biology Aichi Cancer Center Research Institute Nagoya Japan; Division of Molecular and Cellular Oncology Nagoya University Graduate School of Medicine Nagoya Japan Authors' Affiliations: Divisions of 1Medical Oncology and 2Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 3Departments of Thoracic Surgery, Aichi Cancer Center Hospital; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan Department of Clinical Preventive Medicine, Nagoya University Daiko Medical Center, 1-1-20 Daiko-minami, Higashi-ku, Nagoya 461-0047, Japan Authors' Affiliations: 1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, 2Department of Cancer Genetics, Program in Function Construction Medicine, and 3Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute; 5Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital; and 6Institute for Advanced Research, Nagoya University, Nagoya, Japan; Authors' Affiliations: 1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, 2Department of Cancer Genetics, Program in Function Construction Medicine, and 3Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute; 5Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital; and 6Institute for Advanced Research, Nagoya University, Nagoya, Japan Department of Clinical Preventive Medicine, Nagoya University School of Medicine, Tsurumai 65, Showa-ku, Nagoya 466-8560, Japan;; The Prince Charles Hospital, Rode Road, Chermside, Brisbane 4032, Australia;; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593; Biomedicinal Information Research Center (BIRC), Japan Biological Informatics Consortium (JBIC), 2-42 Aomi, Koto-ku, Tokyo 135-0064, Japan, Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya Aichi 464-0021, Japan, and Biomedicinal Information Research Center (BIRC), National Institute of Advanced Industrial Science and Technology (AIST), 2-42 Aomi, Koto-ku, Tokyo 135-0064, Japan Department of Cancer Genetics Nagoya University Graduate School of Medicine Showa‐ku Nagoya 466‐8550 Japan; Division of Molecular Oncology Aichi Cancer Center Research Institute Chikusa‐ku Nagoya 464‐8681 Japan Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi 464‑8681, Japan Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan Department of Cancer Genetics Nagoya University Graduate School of Medicine Nagoya Japan; Division of Cancer Biology Aichi Cancer Center Research Institute Nagoya Japan Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan 1Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.; 6Division of Molecular and Cellular Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. 12Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan. Authors' Affiliations: Departments of 1Respiratory Medicine and Rheumatology and 2Molecular and Environmental Pathology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan; 3Division of Medical Oncology, Molecular and Cellular Targeting Translational Oncology Center, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; 4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan 7Division of Molecular Oncology, Aichi Cancer Center, Nagoya, Japan Authors' Affiliations: Departments of 1Thoracic Surgery and 2Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, and 3Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan; 4Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan; and 5Department of Respiratory Medicine, Higashihiroshima Medical Center, Higashihiroshima, Japan Hamon Center for Therapeutic Oncology Research, Departments of Internal Medicine Pharmacology or Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390; Biology Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan; Department of Clinical Preventive Medicine, Nagoya University School of Medicine, Nagoya 466-8550, Japan; Laboratory of Immunobiology, Center for Cancer Research, National Cancer Institute–Frederick, Frederick, MD 21702; Institut de Biologie... Division of Molecular Oncology Aichi Cancer Center Research Institute Aichi Japan 1Division of Molecular Oncology, Aichi Cancer Center Research Institute; Division of Cancer Biology, Aichi Cancer Center Research Institute Nagoya, Japan. Division of Molecular and Cellular Oncology, Nagoya University Graduate School of Medicine Nagoya, Japan. Authors' Affiliations: 1Division of Molecular Oncology, Aichi Cancer Center Research Institute; Departments of 2Thoracic Surgery and 3Thoracic Oncology, Aichi Cancer Center Hospital; Departments of 4Cardio-Thoracic Surgery and 5Cancer Genetics, Program in Function Construction Medicine, and 6Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan; Authors' Affiliations: 1Division of Molecular Oncology, Aichi Cancer Center Research Institute; Departments of 2Thoracic Surgery and 3Thoracic Oncology, Aichi Cancer Center Hospital; Departments of 4Cardio-Thoracic Surgery and 5Cancer Genetics, Program in Function Construction Medicine, and 6Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, Japan Aichi Cancer Center, Nagoya 464-8681, Japan Department of Clinical Preventive Medicine, Nagoya University Hospital. 3Division of Molecular Oncology, Division of Cancer Biology Aichi Cancer Center Research Institute Nagoya Japan; Department of Molecular and Cellular Oncology Nagoya University Graduate School of Medicine Nagoya Japan National Cancer Center Research Institute, Tokyo 104-0045, Japan; Tokushima University School of Medicine, Tokushima 770-8503, Japan; Nagoya University School of Medicine, Nagoya 466-8550, Japan; and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593 Division of Cancer Biology Aichi Cancer Center Research Institute Nagoya Japan First Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya 466 Division of Molecular Oncology Aichi Cancer Center Research Institute Nagoya Japan; Department of Cancer Genetics Program in Function Construction Medicine Nagoya Japan ‖Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan; and 1Clinical Preventive Medicine, Departments of Department of Cancer Genetics Nagoya University Graduate School of Medicine Nagoya Japan; Division of Molecular Oncology Aichi Cancer Center Research Institute Nagoya Japan Division of Molecular Oncology; Aichi Cancer Center Research Institute; Nagoya, Japan; Department of Cancer Genetics; Nagoya University Graduate School of Medicine; Nagoya, Japan |
Incoming Links
Total number of triples: 202.